Skip to content

Evaluation of the Promoting Effect of "Youbo Gaineoan" Infant Formula Powder on Growth and Development in Infants and Toddlers, and the Characteristics of Digestion and Metabolism in Vivo

Evaluation of the Promoting Effect of "Youbo Gaineoan" Infant Formula Powder on Growth and Development in Infants and Toddlers, and the Characteristics of Digestion and Metabolism in Vivo

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001197
Enrollment
Unknown
Registered
2026-05-07
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant Feeding Issues

Interventions

"Yoboo Gainor" stage 3 formula milk feeding group:"Youbo Ganoan" Stage 3 formula feeding
Non-users of Yobogena formula milk powder group:None

Sponsors

Qingdao University Qingdao Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: a. 11-13 months of age, gender; b. In good health, without congenital diseases, genetic metabolic diseases, etc.; c. Parents sign the informed consent form and are willing to cooperate in completing follow-up, indicator testing, and documentation throughout the study.

Exclusion criteria

Exclusion criteria: a. Individuals allergic to milk protein or components of the study product; b. Infants who have used calcium, iron, and zinc supplements, growth-related intervention medications, or other specialized formula milk within the past 3 months; c. Physical development indicators (height, weight, head circumference) deviate below the WHO child growth curve P3 or above P97.

Design outcomes

Primary

MeasureTime frame
Physical Development Indicators;Core Nutrition Absorption Indices;

Secondary

MeasureTime frame
Multidimensional Nutrient Group Effect Evaluation;

Countries

China

Contacts

Public ContactGao Tianlin

Qingdao University

gaotl@qdu.edu.cn+86 177 0542 5977

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026